首页 > 最新文献

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica最新文献

英文 中文
Can double J stent complications be reduced in pediatric patients? 儿童患者双J支架并发症可以减少吗?
M Bayarri Moreno, I Planas Díaz, I Casal Beloy, R M Romero Ruiz

Objective: The use of double J (DJ) stents is frequent in urological pediatrics, but it is not exempt from morbidity. The objective of this study was to describe the risk factors (RF) of DJ complications in pediatric patients, and to analyze the quality of the information provided to the families with respect to the stent.

Materials and methods: A retrospective study of patients undergoing surgery with DJ placement in the urology department from 2017 to 2022 was carried out. Study patients were divided into two groups -complicated (C) and non-complicated (NC). A multivariate analysis was performed to identify complication-related RFs, and a quality analysis as perceived by the families was conducted by means of a satisfaction survey (0 = total dissatisfaction; 10 = maximum satisfaction).

Results: 180 patients were included (236 DJs). The main diagnoses included renal transplantation (29.8%), ureteropelvic stenosis (26%), and urolithiasis (20.7%). Complication rate was 21.9%, with a mean comprehensive complication index (CCI) of 26.8. Prophylactic antibiotic therapy was not associated with fewer complications (97.3% vs. 98.1%; p= 0.727). Complication RFs included more than one stent (p< 0.001; OR= 6.628) and bilateral placement (p< 0.05; OR= 4.871). Poor registration in the medical records was associated with greater complications (p= 0.025). In the information quality survey, 20% reported a score lower than 7/10.

Conclusions: DJ-associated morbidity has a direct relationship with DJ duration, bilaterality, and carrying more than one stent in a lifetime. Adequate registration in the medical records is associated with shorter DJ duration, and therefore, fewer complications. Antibiotic prophylaxis did not reduce complications, which means its routine use should be reconsidered.

目的:双J(DJ)支架的使用在泌尿外科儿科是常见的,但也不能避免其发病率。本研究的目的是描述儿科患者DJ并发症的危险因素(RF),并分析提供给家庭的支架相关信息的质量。材料和方法:对2017年至2022年在泌尿外科接受DJ植入手术的患者进行回顾性研究。研究患者被分为两组——复杂组(C)和非复杂组(NC)。进行多变量分析以确定与并发症相关的RFs,并通过满意度调查进行家庭感知的质量分析(0= 完全不满;10= 结果:纳入180例患者(236例DJ)。主要诊断包括肾移植(29.8%)、肾盂输尿管狭窄(26%)和尿石症(20.7%),并发症发生率为21.9%,平均综合并发症指数(CCI)为26.8。预防性抗生素治疗与减少并发症无关(97.3%vs.98.1%;p= 0.727)。并发症射频包括多个支架(结论:DJ相关的发病率与DJ持续时间、双侧性和一生中携带一个以上支架有直接关系。医疗记录中的充分登记与DJ持续期较短有关,因此并发症较少。抗生素预防并没有减少并发症,这意味着应重新考虑其常规使用。)。
{"title":"Can double J stent complications be reduced in pediatric patients?","authors":"M Bayarri Moreno,&nbsp;I Planas Díaz,&nbsp;I Casal Beloy,&nbsp;R M Romero Ruiz","doi":"10.54847/cp.2023.04.13","DOIUrl":"https://doi.org/10.54847/cp.2023.04.13","url":null,"abstract":"<p><strong>Objective: </strong>The use of double J (DJ) stents is frequent in urological pediatrics, but it is not exempt from morbidity. The objective of this study was to describe the risk factors (RF) of DJ complications in pediatric patients, and to analyze the quality of the information provided to the families with respect to the stent.</p><p><strong>Materials and methods: </strong>A retrospective study of patients undergoing surgery with DJ placement in the urology department from 2017 to 2022 was carried out. Study patients were divided into two groups -complicated (C) and non-complicated (NC). A multivariate analysis was performed to identify complication-related RFs, and a quality analysis as perceived by the families was conducted by means of a satisfaction survey (0 = total dissatisfaction; 10 = maximum satisfaction).</p><p><strong>Results: </strong>180 patients were included (236 DJs). The main diagnoses included renal transplantation (29.8%), ureteropelvic stenosis (26%), and urolithiasis (20.7%). Complication rate was 21.9%, with a mean comprehensive complication index (CCI) of 26.8. Prophylactic antibiotic therapy was not associated with fewer complications (97.3% vs. 98.1%; p= 0.727). Complication RFs included more than one stent (p< 0.001; OR= 6.628) and bilateral placement (p< 0.05; OR= 4.871). Poor registration in the medical records was associated with greater complications (p= 0.025). In the information quality survey, 20% reported a score lower than 7/10.</p><p><strong>Conclusions: </strong>DJ-associated morbidity has a direct relationship with DJ duration, bilaterality, and carrying more than one stent in a lifetime. Adequate registration in the medical records is associated with shorter DJ duration, and therefore, fewer complications. Antibiotic prophylaxis did not reduce complications, which means its routine use should be reconsidered.</p>","PeriodicalId":94306,"journal":{"name":"Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica","volume":"36 4","pages":"171-179"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Efficacy of sacral transcutaneous electrical nerve stimulation in patients with overactive bladder refractory to anticholinergic treatment: a prospective multi-center study. 骶骨经皮电神经刺激对抗胆碱能治疗难治性膀胱过度活动患者的疗效:一项前瞻性多中心研究。
M Coronas Soucheiron, I Casal Beloy, F N Villalón Ferrero, O Martín Solé, B Capdevila Vilaró, N González Temprano, L Larreina De la Fuente, M García González, M Carbonell Pradas, S Pérez Bertólez, X Tarrado Castellarnau, L García Aparicio, I Somoza Argibay

Objective: To determine whether sacral transcutaneous electrical nerve stimulation (S-TENS) is an effective treatment in patients refractory to anticholinergic drugs (Achs).

Materials and methods: A prospective multi-center study of patients with overactive bladder (OB) refractory to Achs treated with S-TENS from 2018 to 2021 was carried out. S-TENS was applied over 3 months. Symptom progression was assessed using the voiding calendar and the Pediatric Lower Urinary Tract Symptoms Score (PLUTSS), excluding questions 3 and 4 -referring to enuresis- so that progression of daytime symptoms only (LUTS variable) was analyzed.

Results: 66 patients -50% of whom were female- were included, with a mean age of 9.5 years (range: 5-15). S-TENS significantly lowered PLUTSS (19.1 baseline vs. 9.5 final, p< 0.001) and LUTS (13.1 baseline vs. 4.8 final, p< 0.001). It also reduced the number of mictions (8.5 baseline vs. 6.4 final, p< 0.001), while increasing urine volume in the voiding records (214 ml baseline vs. 258 ml final, p< 0.001). Enuresis was the only variable refractory to S-TENS. Complication rate was 3% (2 patients with dermatitis in the S-TENS application area).

Conclusions: S-TENS is effective and safe in the short-term in patients with OB refractory to Achs. Further studies assessing long-term efficacy and potential relapses are required.

目的:确定骶经皮电神经刺激(S-TENS)是否是抗胆碱能药物(Achs)难治性患者的有效治疗方法。材料和方法:对2018年至2021年接受S-TENS治疗的Achs难治性膀胱过度活动症(OB)患者进行前瞻性多中心研究。S-TENS应用时间超过3个月。使用排尿日历和儿童下尿路症状评分(PLUTSS)评估症状进展,排除问题3和问题4(涉及遗尿),以便仅分析日间症状的进展(LUTS变量)。结果:纳入66名患者,其中50%为女性,平均年龄9.5岁(范围:5-15岁)。S-TENS显著降低PLUTSS(19.1基线vs.9.5最终,P结论:S-TENS在短期内对Achs难治性OB患者有效且安全。需要进一步研究评估长期疗效和潜在复发。
{"title":"Efficacy of sacral transcutaneous electrical nerve stimulation in patients with overactive bladder refractory to anticholinergic treatment: a prospective multi-center study.","authors":"M Coronas Soucheiron,&nbsp;I Casal Beloy,&nbsp;F N Villalón Ferrero,&nbsp;O Martín Solé,&nbsp;B Capdevila Vilaró,&nbsp;N González Temprano,&nbsp;L Larreina De la Fuente,&nbsp;M García González,&nbsp;M Carbonell Pradas,&nbsp;S Pérez Bertólez,&nbsp;X Tarrado Castellarnau,&nbsp;L García Aparicio,&nbsp;I Somoza Argibay","doi":"10.54847/cp.2023.04.14","DOIUrl":"10.54847/cp.2023.04.14","url":null,"abstract":"<p><strong>Objective: </strong>To determine whether sacral transcutaneous electrical nerve stimulation (S-TENS) is an effective treatment in patients refractory to anticholinergic drugs (Achs).</p><p><strong>Materials and methods: </strong>A prospective multi-center study of patients with overactive bladder (OB) refractory to Achs treated with S-TENS from 2018 to 2021 was carried out. S-TENS was applied over 3 months. Symptom progression was assessed using the voiding calendar and the Pediatric Lower Urinary Tract Symptoms Score (PLUTSS), excluding questions 3 and 4 -referring to enuresis- so that progression of daytime symptoms only (LUTS variable) was analyzed.</p><p><strong>Results: </strong>66 patients -50% of whom were female- were included, with a mean age of 9.5 years (range: 5-15). S-TENS significantly lowered PLUTSS (19.1 baseline vs. 9.5 final, p< 0.001) and LUTS (13.1 baseline vs. 4.8 final, p< 0.001). It also reduced the number of mictions (8.5 baseline vs. 6.4 final, p< 0.001), while increasing urine volume in the voiding records (214 ml baseline vs. 258 ml final, p< 0.001). Enuresis was the only variable refractory to S-TENS. Complication rate was 3% (2 patients with dermatitis in the S-TENS application area).</p><p><strong>Conclusions: </strong>S-TENS is effective and safe in the short-term in patients with OB refractory to Achs. Further studies assessing long-term efficacy and potential relapses are required.</p>","PeriodicalId":94306,"journal":{"name":"Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica","volume":"36 4","pages":"180-185"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dysphagia in patients undergoing esophageal atresia surgery: Assessment using a functional scale. 食管闭锁手术患者的吞咽困难:功能量表评估。
P Salcedo Arroyo, C Corona Bellostas, P Vargova, R Fernández Atuan, P Bragagnini Rodríguez, R García Romero, I Ros Arnal, M J Romea Montañés, R Escartín Villacampa

Introduction: Dysphagia is defined as difficulty swallowing. Up to 84% of patients undergoing esophageal atresia surgery have dysphagia beyond the neonatal period.

Materials and methods: A retrospective study of patients undergoing esophageal atresia surgery from 2005 to 2021 was carried out. The Functional Oral Intake Scale (FOIS) was used to assess dysphagia in 4 age groups (< 1 year old, 1-4 years old, 5-11 years old, and > 11 years old). FOIS scores < 7 or symptoms of choking, impaction, or food aversion were regarded as dysphagia.

Results: 63 patients were analyzed. 74% (47/63) had dysphagia during follow-up. Prevalence was 50% in patients < 1 year old (FOIS mean 4.32), 77% in patients aged 1-4 (FOIS mean 5.61), 45% in patients aged 5-11 (FOIS mean 5.87), and 38% in patients > 11 years old (FOIS mean 6.8). The most frequent causes of dysphagia were stenosis, which occurred in 38% of the patients (n=24), and gastroesophageal reflux (n=18), which was present in 28% of the patients. Both conditions were associated with significantly lower mean FOIS scores (p< 0.05) in the patients under 11 years of age. Differences (p< 0.05) were found in the dysphagia-associated perinatal factors in the various age groups, with longer ventilation assistance times, parenteral nutrition, and hospital stays.

Conclusions: Dysphagia is an extremely frequent symptom at any given age in patients undergoing esophageal atresia surgery. A standardized, cross-disciplinary follow-up is key to improve quality of life.

引言:吞咽困难是指吞咽困难。在接受食道闭锁手术的患者中,高达84%的患者在新生儿期后出现吞咽困难。材料和方法:对2005年至2021年接受食管闭锁手术的患者进行回顾性研究。功能性口腔摄入量表(FOIS)用于评估4个年龄组的吞咽困难( 11岁)。FOIS评分结果:对63例患者进行分析。74%(47/63)在随访期间出现吞咽困难。患者的患病率为50% 11岁(FOIS平均6.8)。吞咽困难最常见的原因是狭窄,38%的患者(n=24)和胃食管反流(n=18),28%的患者存在胃食管反流病。这两种情况都与平均FOIS评分显著降低有关(P结论:在接受食管闭锁手术的患者中,吞咽困难在任何特定年龄段都是一种极其常见的症状。标准化、跨学科的随访是提高生活质量的关键。
{"title":"Dysphagia in patients undergoing esophageal atresia surgery: Assessment using a functional scale.","authors":"P Salcedo Arroyo,&nbsp;C Corona Bellostas,&nbsp;P Vargova,&nbsp;R Fernández Atuan,&nbsp;P Bragagnini Rodríguez,&nbsp;R García Romero,&nbsp;I Ros Arnal,&nbsp;M J Romea Montañés,&nbsp;R Escartín Villacampa","doi":"10.54847/cp.2023.04.10","DOIUrl":"https://doi.org/10.54847/cp.2023.04.10","url":null,"abstract":"<p><strong>Introduction: </strong>Dysphagia is defined as difficulty swallowing. Up to 84% of patients undergoing esophageal atresia surgery have dysphagia beyond the neonatal period.</p><p><strong>Materials and methods: </strong>A retrospective study of patients undergoing esophageal atresia surgery from 2005 to 2021 was carried out. The Functional Oral Intake Scale (FOIS) was used to assess dysphagia in 4 age groups (< 1 year old, 1-4 years old, 5-11 years old, and > 11 years old). FOIS scores < 7 or symptoms of choking, impaction, or food aversion were regarded as dysphagia.</p><p><strong>Results: </strong>63 patients were analyzed. 74% (47/63) had dysphagia during follow-up. Prevalence was 50% in patients < 1 year old (FOIS mean 4.32), 77% in patients aged 1-4 (FOIS mean 5.61), 45% in patients aged 5-11 (FOIS mean 5.87), and 38% in patients > 11 years old (FOIS mean 6.8). The most frequent causes of dysphagia were stenosis, which occurred in 38% of the patients (n=24), and gastroesophageal reflux (n=18), which was present in 28% of the patients. Both conditions were associated with significantly lower mean FOIS scores (p< 0.05) in the patients under 11 years of age. Differences (p< 0.05) were found in the dysphagia-associated perinatal factors in the various age groups, with longer ventilation assistance times, parenteral nutrition, and hospital stays.</p><p><strong>Conclusions: </strong>Dysphagia is an extremely frequent symptom at any given age in patients undergoing esophageal atresia surgery. A standardized, cross-disciplinary follow-up is key to improve quality of life.</p>","PeriodicalId":94306,"journal":{"name":"Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica","volume":"36 4","pages":"152-158"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41224697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1